Mollie Barnard, ScD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Hematology & Medical Oncology

ScD, Harvard School of Public Health
BA, Swarthmore College

Dr. Barnard is a molecular and genetic epidemiologist whose research focuses on the epidemiology of breast and ovarian cancers. She is especially interested in identifying modifiable factors that contribute to racial and ethnic disparities in breast cancer risk and survival, and characterizing the molecular and genetic etiology of ovarian cancer.

Center Faculty Member
Boston University Chobanian & Avedisian School of Medicine
Slone Epidemiology Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Lawson-Michod KA, Watt MH, Grieshober L, Green SE, Karabegovic L, Derzon S, Owens M, McCarty RD, Doherty JA, Barnard ME. Pathways to ovarian cancer diagnosis: a qualitative study. BMC Womens Health. 2022 Nov 04; 22(1):430. PMID: 36333689; PMCID: PMC9636716; DOI: 10.1186/s12905-022-02016-1;
  2. Blair LK, Warner ET, James P, Hart JE, VoPham T, Barnard ME, Newton JD, Murthy DJ, Laden F, Tamimi RM, DuPre NC. Exposure to natural vegetation in relation to mammographic density in a Massachusetts-based clinical cohort. Environ Epidemiol. 2022 Aug; 6(4):e216. PMID: 35975164; PMCID: PMC9374192; DOI: 10.1097/EE9.0000000000000216;
  3. Barnard ME, Martheswaran T, Van Meter M, Buys SS, Curtin K, Doherty JA. Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study. Cancer Epidemiol Biomarkers Prev. 2022 Jul 01; 31(7):1313-1323. PMID: 35511751; PMCID: PMC9250611; DOI: 10.1158/1055-9965.EPI-21-1249;
  4. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA. Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet. 2023 Feb; 60(2):119-127. PMID: 35534206; PMCID: PMC9643667; DOI: 10.1136/jmedgenet-2021-108402;
  5. Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, Terry P, Alberg AJ, Bandera EV, Funkhouser E, Wu AH, Pearce CL, Pike M, Setiawan VW, Haiman CA, Palmer JR, LeMarchand L, Wilkens LR, Berchuck A, Doherty JA, Modugno F, Ness R, Moysich K, Karlan BY, Whittemore AS, McGuire V, Sieh W, Lawrenson K, Gayther S, Sellers TA, Pharoah P, Schildkraut JM. Identification of novel epithelial ovarian cancer loci in women of African ancestry. Int J Cancer. 2020 06 01; 146(11):2987-2998.View Related Profiles. PMID: 31469419; PMCID: PMC7523187; DOI: 10.1002/ijc.32653;
  6. Barnard ME, Beeghly-Fadiel A, Milne GL, Akam EY, Chan AT, Eliassen AH, Rosner BA, Shu XO, Terry KL, Xiang YB, Zheng W, Tworoger SS. Urinary PGE-M Levels and Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1845-1852. PMID: 31387969; PMCID: PMC6825569; DOI: 10.1158/1055-9965.EPI-19-0597;
  7. Simon TG, Barnard ME, Chan AT. Aspirin Use and the Risk of Cancer-In Reply. JAMA Oncol. 2019 06 01; 5(6):913. PMID: 31046070; DOI: 10.1001/jamaoncol.2019.0633;
  8. Barnard ME, Poole EM, Curhan GC, Eliassen AH, Rosner BA, Terry KL, Tworoger SS. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. JAMA Oncol. 2018 12 01; 4(12):1675-1682. PMID: 30286239; PMCID: PMC6400245; DOI: 10.1001/jamaoncol.2018.4149;
  9. Barnard ME, Hecht JL, Rice MS, Gupta M, Harris HR, Eliassen AH, Rosner BA, Terry KL, Tworoger SS. Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1509-1517. PMID: 30377203; PMCID: PMC6415678; DOI: 10.1158/1055-9965.EPI-18-0346;
  10. Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, Tworoger SS. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. Lancet Oncol. 2018 08; 19(8):1107-1116. PMID: 30029888; PMCID: PMC6242286; DOI: 10.1016/S1470-2045(18)30373-5;
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 9 distinct years, with a maximum of 4 publications in 2018 and 2022


2021 HCI, Salt Lake City, UT: Women’s Cancers Center Rising Star Award
2021 American Association for Cancer Research: Molecular Epidemiology Working Group Scholar-in-Training Award
2020 HCI, Salt Lake City, UT: Susan Cooper Jones Endowed Fellowship in Cancer Research
2020 HCI, Salt Lake City, UT: Huntsman Travel Fellowship
2019 University of Utah, Salt Lake City, UT: Postdoc Travel Assistance Award ($500 travel award)
2019 HCI, Salt Lake City, UT: Huntsman Travel Fellowship ($1,500 travel award)
2019 National Cancer Institute: Epidemiology and Genomics Research Program Research Highlight
2016 Harvard TH Chan School of Public Health: Nominee for the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award
Contact for Mentoring:

72 E. Concord St
Boston MA 02118
Google Map

Barnard's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department